Eli Lily and CEO and CEO of Dave Rix on his “achievement” in weight loss research research, focusing on US production and lowering copy prices even among tariffs.
A new daily weight loss pill can be as popular as an injection that helps patients lower their blood sugar and lose unwanted weight.
“I think we are really at the beginning of the new era of chronic disease,” Dave Rix said. In “Morning with Maria” Friday
“This is the first seven studies we do to study this drug,” he said.
On Thursday, Eli Lily released data on Phase 3 tests from a daily weight loss pill that does not require refrigerators, foods, water or water after consumption. The results showed that the pill was exactly as well as Ompic, while patients lose an average of 16 pounds.
Stocks after Powell's tariff alert, Trump has come back: live updates
Eli Lily's shares climbed 16 % of the news.
Eli Lily has released new data on daily weight loss pills and shows that it works exactly as well as Ozempic. (Pictures of Gitti)
“(This is a big moment because people are normally better than injectable,” Rix said.
According to the CEO, the experimental studies will continue during the 2025, before it is expected to reach the FDA by the end of the year. The release date of the anticipated market for 2026 is set.
“These drugs not only help people look better and feel better, but our weight management is one of the most important things we can do to prevent chronic illnesses,” Rix said.
Dr. Mark Siegel, a senior medical analyst at Fox News, reports the latest weight loss drugs in “Big Money Show”.
“There are more than 200 chronic diseases that can be improved if weight is controlled, and some are obvious, such as myocardial infarction and stroke, which we think of, diabetes, (AS), but some of them, such as inflammation and joint pain, are less obvious,” he said.
Several other companies are investigating the development of weight loss pills and are expected to sell obesity treatments $ 150 billion in the coming yearsReuters reported. But Eli Lily's latest data gives them an edge.
Get Fox Business on a move by clicking here
Jeffrey Martha, chief and CEO of Medtronic, says Robotics is growing in “CLAMAN COUNTDOWN”.
“We will be ready. We want to make this medicine Here in the United States. We build the biggest, what we call the API factory, the “active drug” in the history of the country, just on the road where I stand today.
“We are deeply committed to that agenda, which I know is this government as well,” he continued. “So we want to work with them to accelerate these factories, employ workers, and make these amazing new new drugs on a scale. They will be exported. We will make them for the world in our country.”